Internal Radiotherapy
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Study to Evaluate Efficacy and Safety of Selective Internal Radiation Therapy Plus Xelox, Bevacizumab and Atezolizumab (Immune Chekpoint Inhibitor) in Patients With Liver-dominant Metastatic Colorectal Cancer (NCT04659382) | Federation Francophone de Cancerologie Digestive | 2020-10-07 |
Track Internal Radiotherapy automatically
Every clearance here is in the API, with alerts when new ones post.